Inventor · disambiguated record
Emil D. Kakkis
Also filed as: KAKKIS EMIL · KAKKIS EMIL D
44 granted patents·40 pending applications·822 citations·filing 1999–2024
98Inventor score
Files withULTRAGENYX PHARMACEUTICAL INC33BIOMARIN PHARM INC26KAKKIS EMIL D7OPPENHEIMER DANIEL I3HARBOR UCLA RES & EDUCATION2
Top patents by PatentIndex Score
84 records- 0198US7531341B1Compositions of prokaryotic phenylalanine ammonia-lyase and methods of using compositions thereofBIOMARIN PHARM INC·Filed 2006·Granted May 12, 2009·87 cites·6 claims
- 0297US7534595B2Compositions of prokaryotic phenylalanine ammonia-lyase and methods of using compositions thereofBIOMARIN PHARM INC·Filed 2007·Granted May 19, 2009·79 cites·34 claims
- 0397US7442372B2Delivery of therapeutic compounds to the brain and other tissuesBIOMARIN PHARM INC·Filed 2003·Granted Oct 28, 2008·109 cites·49 claims
- 0496US9993481B2Methods and compositions for the treatment of metabolic disordersBIOMARIN PHARM INC·Filed 2016·Granted Jun 12, 2018·11 cites·20 claims
- 0596US7560263B2Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereofBIOMARIN PHARM INC·Filed 2008·Granted Jul 14, 2009·81 cites·26 claims
- 0696US7537923B2Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereofBIOMARIN PHARM INC·Filed 2008·Granted May 26, 2009·49 cites·9 claims
- 0795US7566714B2Methods and compositions for the treatment of metabolic disordersBIOMARIN PHARM INC·Filed 2005·Granted Jul 28, 2009·15 cites·46 claims
- 0894US8067416B2Methods and compositions for the treatment of metabolic disordersOPPENHEIMER DANIEL I·Filed 2009·Granted Nov 29, 2011·12 cites·24 claims
- 0994US7790433B2Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereofBIOMARIN PHARM INC·Filed 2009·Granted Sep 7, 2010·32 cites·6 claims
- 1094US6858206B2Methods for treating diseases caused by deficiencies of recombinant alpha-L-iduronidaseFiled 2001·Granted Feb 22, 2005·52 cites·46 claims
- 1193US9433624B2Methods and compositions for the treatment of metabolic disordersOPPENHEIMER DANIEL I·Filed 2011·Granted Sep 6, 2016·10 cites·12 claims
- 1291US6569661B1Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereofBIOMARIN PHARM INC·Filed 2000·Granted May 27, 2003·63 cites·10 claims
- 1390US11771748B2Methods for treating tumor-induced osteomalaciaULTRAGENYX PHARMACEUTICAL INC·Filed 2021·Granted Oct 3, 2023·1 cites·9 claims
- 1490US11202822B2Methods for treating hypophosphatemic disordersULTRAGENYX PHARMACEUTICAL INC·Filed 2020·Granted Dec 21, 2021·2 cites·9 claims
- 1590US9572870B2Delivery of therapeutic compounds to the brain and other tissuesBIOMARIN PHARM INC·Filed 2015·Granted Feb 21, 2017·6 cites·16 claims
- 1690US9089566B2Delivery of therapeutic compounds to the brain and other tissuesKAKKIS EMIL D·Filed 2012·Granted Jul 28, 2015·11 cites·12 claims
- 1790US8377884B2Variants of C-type natriuretic peptidesBIOMARIN PHARM INC·Filed 2008·Granted Feb 19, 2013·27 cites·24 claims
- 1890US6585971B1Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating disease caused by deficiencies thereofHARBOR UCLA RES & EDUCATION·Filed 2000·Granted Jul 1, 2003·30 cites·30 claims
- 1988US9554987B2Methods and formulations for treating sialic acid deficienciesULTRAGENYX PHARMACEUTICAL INC·Filed 2013·Granted Jan 31, 2017·4 cites·22 claims
- 2087US7354576B2Methods of treating diseases caused by deficiencies of recombinant α-L-iduronidaseBIOMARIN PHARM INC·Filed 2004·Granted Apr 8, 2008·20 cites·11 claims
- 2186US12358976B2Methods for increasing serum concentration of phosphorous and/or 1,25-hydroxy vitamin dULTRAGENYX PHARMACEUTICAL INC·Filed 2023·Granted Jul 15, 2025·0 cites·20 claims
- 2286US11753369B2Creatine prodrugs, compositions and methods of use thereofULTRAGENYX PHARMACEUTICAL INC·Filed 2022·Granted Sep 12, 2023·1 cites·20 claims
- 2386US10639360B2Methods for treating hypophosphatemic disordersULTRAGENYX PHARMACEUTICAL INC·Filed 2015·Granted May 5, 2020·3 cites·14 claims
- 2486US9241896B2Methods and formulations for treating sialic acid deficienciesULTRAGENYX PHARMACEUTICAL INC·Filed 2012·Granted Jan 26, 2016·4 cites·12 claims
- 2586US2024245759A1Sialylated glycoprotein compositions and uses thereofULTRAGENYX PHARMACEUTICAL INC·Filed 2023·Application pending·0 cites
- 2686US2025120936A1Compositions of triglycerides and uses thereofULTRAGENYX PHARMACEUTICAL INC·Filed 2024·Application pending·0 cites
- 2786US2025120935A1Compositions of triglycerides and uses thereofULTRAGENYX PHARMACEUTICAL INC·Filed 2024·Application pending·0 cites
- 2885US9511015B2Methods and formulations for treating sialic acid deficienciesKAKKIS EMIL·Filed 2011·Granted Dec 6, 2016·5 cites·16 claims
- 2985US9044473B2Delivery of therapeutic compounds to the brain and other tissuesKAKKIS EMIL D·Filed 2004·Granted Jun 2, 2015·14 cites·42 claims
- 3085US2025120934A1Compositions of triglycerides and uses thereofULTRAGENYX PHARMACETICAL INC·Filed 2024·Application pending·0 cites
- 3184US10065981B2Sialic acid analogsULTRAGENYX PHARMACEUTICAL INC·Filed 2015·Granted Sep 4, 2018·4 cites·33 claims
- 3282US11332438B2Creatine prodrugs, compositions and methods of use thereofULTRAGENYX PHARMACEUTICAL INC·Filed 2018·Granted May 17, 2022·2 cites·23 claims
- 3382US9221858B2Sialic acid analogsULTRAGENYX PHARMACEUTICAL INC·Filed 2014·Granted Dec 29, 2015·4 cites·35 claims
- 3482US7485314B2Induction of antigen specific immunologic toleranceLOS ANGELES BIOMED RES INST·Filed 2002·Granted Feb 3, 2009·25 cites·13 claims
- 3580US11505790B2Compositions of prokaryotic phenylalanine ammonia-lyase variants and methods of using compositions thereofBIOMARIN PHARM INC·Filed 2019·Granted Nov 22, 2022·1 cites·14 claims
- 3680US10221408B2Compositions of prokaryotic phenylalanine ammonia-lyase variants and methods of using compositions thereofBIOMARIN PHARM INC·Filed 2016·Granted Mar 5, 2019·3 cites·18 claims
- 3779US6426208B1Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereofHARBOR UCLA RES & EDUCATION·Filed 1999·Granted Jul 30, 2002·42 cites·7 claims
- 3878US8324210B2Pterin analogsKAKKIS EMIL D·Filed 2009·Granted Dec 4, 2012·2 cites·7 claims
- 3978US7601717B2Pterin analogsBIOMARIN PHARM INC·Filed 2008·Granted Oct 13, 2009·2 cites·5 claims
- 4078US2023127775A1Methods and compositions for the treatment of amyloidosisULTRAGENYX PHARMACEUTICAL INC·Filed 2022·Application pending·0 cites
- 4177US10457701B2Sialic acid analogsULTRAGENYX PHARMACEUTICAL INC·Filed 2018·Granted Oct 29, 2019·1 cites·15 claims
- 4277US2022202915A1Sialylated glycoprotein compositons and uses thereofULTRAGENYX PHARMACEUTICAL INC·Filed 2021·Application pending·0 cites
- 4377US2024092731A1Creatine prodrugs, compositions and methods of use thereofULTRAGENYX PHARMACEUTICAL INC·Filed 2023·Application pending·0 cites
- 4476US2024035013A1Compositions of prokaryotic phenylalanine ammonia-lyase variants and methods of using compositions thereofBIOMARIN PHARM INC·Filed 2022·Application pending·0 cites
- 4574US9687532B2Sialylated glycoprotein compositons and uses thereofULTRAGENYX PHARMACEUTICAL INC·Filed 2016·Granted Jun 27, 2017·1 cites·17 claims
- 4674US7883707B2Induction of antigen specific immunnologic toleranceKAKKIS EMIL D·Filed 2009·Granted Feb 8, 2011·3 cites·37 claims
- 4773US10889607B2Sialic acid analogsULTRAGENYX PHARMACEUTICAL INC·Filed 2019·Granted Jan 12, 2021·0 cites·20 claims
- 4872US9457068B2Sialylated glycoprotein compositions and uses thereofULTRAGENYX PHARMACEUTICAL INC·Filed 2015·Granted Oct 4, 2016·1 cites·9 claims
- 4971US9457067B2Sialylated glycoprotein compositions and uses thereofULTRAGENYX PHARMACEUTICAL INC·Filed 2015·Granted Oct 4, 2016·1 cites·12 claims
- 5071US2018256582A1Methods and compositions for the treatment of metabolic disordersBIOMARIN PHARM INC·Filed 2018·Application pending·0 cites
Showing the top 50 of 84 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Emil D. Kakkis files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →